CDX2 and neoplasm: When applying these markers in the diagnostics of tumors of uncertain origin, it needs to be noted that loss of CDX2 and SATB2 expression was associated with higher tumor grade, proximal tumor location, BRAF mutation, and dMMR, which also corresponds with the findings of the previous studies [7, 15, 36, 41, 42].